Treeway B.V. and LACDR collaborate on ALS therapy development

Treeway and LACDR at the University of Leiden join forces and form a collaboration focused on the optimisation of clinical trial designs and data-analysis for ALS (Amyotrophic Lateral Sclerosis) through the use of population disease progression models. Furthermore both parties aim to obtain a better understanding of the disease by developing ALS physiology-based disease models and to test the effect of interventions in the different identified pathways.

Source: Pharmacy Europe - October 15, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Industry News clinical trial design disease progression models Latest News Source Type: news